Clinical Trials Directory

Trials / Completed

CompletedNCT03210883

Global Electrical Heterogeneity and Clinical Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
3,471 (actual)
Sponsor
Larisa Tereshchenko · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

This retrospective multicenter cohort will validate an independent association of electrocardiographic (ECG) global electrical heterogeneity (GEH) measures with sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD, and will validate and re-calibrate GEH ECG risk score for prediction of sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD.

Conditions

Timeline

Start date
2017-07-01
Primary completion
2021-07-05
Completion
2021-07-05
First posted
2017-07-07
Last updated
2021-07-08

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03210883. Inclusion in this directory is not an endorsement.

Global Electrical Heterogeneity and Clinical Outcomes (NCT03210883) · Clinical Trials Directory